NCT06347016Phase 3Active not recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

Study sponsor: Arrowhead Pharmaceuticals

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-06-17Actual
Enrollment · participants311Actual
Source updated2026-08-06Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 2 fields changed

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Jun 2026

+ After

17 Jun 2026

Check registry source